Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of cardiovascular diseases in cancer patients.

Literature DB >> 21584714

Treatment of cardiovascular diseases in cancer patients.

Abstract

Cardiovascular diseases and cancer are the leading causes of death in the Western world. Cancer treatment has been associated with cardiovascular complications, among others cardiotoxicity of mediastinal radiation and certain chemotherapeutics. Identification of patients at high risk, prevention, early diagnosis, and treatment of cardiovascular diseases are emerging fields in cancer patients. Close interdisciplinary work between oncologists and cardiologists is pertinent for the treatment of cardiovascular diseases and complications in cancer patients. Diagnostics and treatment applied to the individual case should be based on the available evidence in terms of patient-centered management. Further clinical research focused on the pathogenesis and treatment of cardiovascular diseases in cancer patients is warranted to pave the way to guidelines for this nonhomogeneous patient group.

Entities: Disease Species

Mesh：

Year: 2011 PMID： 21584714 DOI： 10.1007/s00059-011-3452-5

Source DB: PubMed Journal: Herz ISSN： 0340-9937 Impact factor: 1.443

56 in total

1. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal: Circulation Date: 2007-08-06 Impact factor: 29.690

2. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index.

Authors: Eric Boersma; Miklos D Kertai; Olaf Schouten; Jeroen J Bax; Peter Noordzij; Ewout W Steyerberg; Arend F L Schinkel; Marian van Santen; Maarten L Simoons; Ian R Thomson; Jan Klein; Hero van Urk; Don Poldermans
Journal: Am J Med Date: 2005-10 Impact factor: 4.965

3. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery.

Authors: L Broad; T Lee; M Conroy; S Bolsin; N Orford; A Black; G Birdsey
Journal: Br J Anaesth Date: 2006-11-22 Impact factor: 9.166

4. Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.

Authors: Edwin P Rock; Vicki Goodman; Janet X Jiang; Kooros Mahjoob; S Leigh Verbois; David Morse; Ramzi Dagher; Robert Justice; Richard Pazdur
Journal: Oncologist Date: 2007-01

5. Platelet inhibition with prasugrel and increased cancer risks: potential causes and implications.

Authors: Victor L Serebruany
Journal: Am J Med Date: 2009-05 Impact factor: 4.965

6. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery.

Authors: Emmanouil S Brilakis; James L Orford; Panayotis Fasseas; Stephanie H Wilson; Steven Melby; Ryan J Lennon; Peter B Berger
Journal: Am J Cardiol Date: 2005-08-15 Impact factor: 2.778

7. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

Authors: J D Hidalgo; R Krone; M W Rich; K Blum; D Adkins; M-Y Fan; R Brown; S Devine; T Graubert; W Blum; M Tomasson; L T Goodnough; R Vij; J DiPersio; H Khoury
Journal: Bone Marrow Transplant Date: 2004-10 Impact factor: 5.483

Treatment of cardiovascular diseases in cancer patients.

2. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index.

3. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery.

4. Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.

5. Platelet inhibition with prasugrel and increased cancer risks: potential causes and implications.

6. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery.

7. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

8. Critical stenosis of aortic and mitral valves after mediastinal irradiation.

9. Percutaneous coronary intervention in anticoagulated patients via radial artery access.

10. High-dose ifosfamide is associated with severe, reversible cardiac dysfunction.

Review 1. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.